ResearcherHarbin Medical UniversityNo recent work listed

Zhiqiang Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6760-6950; OpenAlex author ID A5100346713. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper

Papers 1

Dictamnine inhibits pancreatic cancer cell growth and epithelial-mesenchymal transition by blocking the PI3K/AKT signaling pathway. Co-author DOI 10.4149/neo_2022_211016n1474 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ye Song · 1 shared paper, 2022 · strength 0.16
- Paper Dictamnine inhibits pancreatic cancer cell growth and epithelial-mesenchymal transition by blocking the PI3K/AKT signal… DOI 10.4149/neo_2022_211016n1474 ↗
Dongbo Xue · 1 shared paper, 2022 · strength 0.16
- Paper Dictamnine inhibits pancreatic cancer cell growth and epithelial-mesenchymal transition by blocking the PI3K/AKT signal… DOI 10.4149/neo_2022_211016n1474 ↗
Weihui Zhang · 1 shared paper, 2022 · strength 0.16
- Paper Dictamnine inhibits pancreatic cancer cell growth and epithelial-mesenchymal transition by blocking the PI3K/AKT signal… DOI 10.4149/neo_2022_211016n1474 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.